Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Irinotecan × Clear all

NCT00089128 2018-07-12

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Phase 2 Terminated

16 enrolled 4 charts

Urinary Bladder Neoplasms

NCT00066612 2012-11-02

S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy

Phase 2 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms